Laboratorios Farmaceuticos Rovi (ROVI)

Index:

IBEX 35

  53.90
   
  • 52 Week High:  90.45
  • 52 Week Low:  42.40
  • Currency: Euro
  • Shares Issued: 51.21m
  • Market Cap:  2,760.22m
  • RiskGrade: 165
  • Beta: 0.51

Fundamentals - based on IFRS

    (Millions)   (Millions)   (Millions)   (Millions)   (Millions)
Income Statement 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20
Continuing Operations          
Revenue 763.75 829.51 817.70 648.68 459.42
Operating Profit/(Loss) 178.71 220.25 255.85 181.39 45.25
Profit Before Tax 177.69 220.41 257.97 182.63 75.22
Profit After Tax 136.88 170.30 199.66 153.08 71.14
           
Earnings per Share - Basic 267.00¢ 320.00¢ 373.00¢ 276.00¢ 110.00¢
Earnings per Share - Adjusted 267.00¢ 320.00¢ 373.00¢ 276.00¢ 110.00¢
           
Dividend per Share 94.00¢ 129.38¢ 95.56¢ 38.12¢ 17.51¢
    (Millions)   (Millions)   (Millions)   (Millions)   (Millions)
Balance Sheet 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20
Assets          
Non-Current Assets          
Property, Plant & Equipment 286.62 253.65 215.54 181.77 52.13
Intangible Assets 28.23 33.90 35.74 38.56 37.49
Other Non-Current Assets 27.56 3.00 4.34 5.98 51.88
  342.41 290.55 255.63 226.31 141.50
Current Assets          
Inventories 329.95 337.97 311.94 245.47 74.68
Cash at Bank & in Hand 27.19 25.32 124.94 99.04 34.14
Other Current Assets 132.47 146.04 186.18 161.85 305.21
  489.61 509.33 623.07 506.36 414.03
           
Other Assets n/a n/a n/a n/a n/a
Total Assets 832.02 799.88 878.70 732.68 555.53
Current Liabilities          
Borrowings 23.69 13.19 12.73 6.42 0.17
Other Current Liabilities 132.96 186.66 281.16 183.97 160.53
           
Current Liabilities 156.65 199.85 293.89 190.39 160.71
           
Net Current Assets c332.96 c309.48 c329.19 c315.97 c253.32
           
Borrowings 90.72 52.24 59.44 66.75 44.83
Other Non-Current Liabilities 3.11 4.30 4.00 4.57 19.31
Non-Current Liabilities 93.83 56.54 63.44 71.31 64.14
           
Other Liabilities n/a n/a n/a n/a n/a
Total Liabilities 250.48 256.39 357.32 261.70 224.84
           
Net Assets 581.54 543.49 521.38 470.98 330.69
           
Shareholders Funds 581.54 539.39 520.01 470.98 330.69
           
Minority Interests/Other Equity n/a 4.10 1.37 n/a n/a
Total Equity 581.54 543.49 521.38 470.98 330.69
Cash Flow 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20
Net Cash Flow From Operating Activities 4,965.00 113.25 237.60 149.44 13.90
Net Cash Flow from Investing Activities (2,694.00) (52.03) (57.15) (40.84) 10.26
Net Cash Flow from Financing Activities (1,642.00) (160.84) (154.54) (62.73) (20.82)
Net Increase/Decrease In Cash 629.00 (99.62) 25.91 45.87 3.35
Ratios - based on IFRS 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20
Continuing Operations          
PE Ratio - Adjusted 23.6 18.8 9.7 26.7 n/a
PEG - Adjusted n/a n/a 0.3 0.2 n/a
Earnings per Share Growth - Adjusted -17% -14% 35% 151% 57%
Dividend Cover 2.84 2.47 3.90 7.24 6.28
Revenue per Share 1,491.41¢ 1,619.82¢ 1,596.76¢ 1,266.70¢ 897.14¢
Pre-Tax Profit per Share 346.98¢ 430.40¢ 503.74¢ 356.63¢ 146.88¢
Operating Margin 23.40% 26.55% 31.29% 27.96% 9.85%
Return on Capital Employed 26.61% 38.33% 46.25% 36.12% 22.24%
           
Dividend Yield 1.5% 2.1% 2.7% 0.5% 0.0%
Dividend per Share Growth (27.35%) 35.39% 150.68% 117.70% 119.42%
Operating Cash Flow per Share 9,695.37¢ 221.15¢ 463.98¢ 291.82¢ 27.15¢
Cash Incr/Decr per Share 1,228.28¢ (194.53¢) 50.60¢ 89.58¢ 6.54¢
Net Asset Value per Share (exc. Intangibles) 1,080.47¢ 995.10¢ 948.32¢ 844.40¢ 572.54¢
Net Gearing 15.00% 7.44% -10.15% -5.49% 3.28%

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

Top of Page